Condition
Ornithine Transcarbamylase Deficiency clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Ornithine Transcarbamylase Deficiency clinical trials that are recruiting, at sites in 3 countries (most in United States (3), United Kingdom (2), France (1)). By phase: Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest Ornithine Transcarbamylase Deficiency clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Long-term follow-up for participants in an iECURE protocol | — | Aurora, Colorado and 3 other locations | Recruiting | Feb 3, 2025 |
| Evaluating ARCT-810 for treating OTC deficiency | Phase 2 | Chevy Chase, Maryland | Recruiting | Jul 5, 2024 |
| Gene therapy for children with Ornithine Transcarbamylase deficiency | Phase 1/2 | London | Recruiting | Oct 25, 2021 |
| Evaluating liver tissue in patients with urea cycle disorders | — | Washington D.C., District of Columbia and 1 other locations | Recruiting | Jun 1, 2021 |
All recruiting trials (4)
-
Long-term follow-up for participants in an iECURE protocol
This study looks at the long-term safety and effectiveness of a treatment for people who have already been part of an earlier study, while also tracking the health of those who didn’t receive the treatment.
-
Evaluating ARCT-810 for treating OTC deficiency
This study is testing a new treatment called ARCT-810 to see if it can help adolescents and adults with OTC deficiency feel better while they continue their usual care.
-
Gene therapy for children with Ornithine Transcarbamylase deficiency
This study is testing a new gene therapy for children with Ornithine Transcarbamylase deficiency to see if it can help their liver produce a missing enzyme and reduce dangerous ammonia levels in their blood.
-
Evaluating liver tissue in patients with urea cycle disorders
This study looks at liver tissue from people with urea cycle disorders to see how these conditions affect the liver, especially in those who have had a liver transplant or biopsy.
Related topics
Quick answers
How many Ornithine Transcarbamylase Deficiency clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), United Kingdom (2 trials), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.